Author | Jeffrey Vacirca, MD


Jeffrey Vacirca on How the COA Advocates for Community Oncology Practices and Patients

July 15, 2017

In this interview we discuss the goals of the Community Oncology Alliance, highlights from their annual meeting, and the challenge of transitioning cancer care to the hospital setting.

The 340b Drug Discount Program: Oncology's Optical Illusion

November 15, 2013

The historical rationale for the 340b program is a good one: indigent patients do need reliable access to prescription drugs, and entities meeting this need should be supported. However, the evolution of the 340b program has strayed widely from its original intent.